Selected article for: "ARDS respiratory distress syndrome and viral infection"

Author: Shetty, Rohit; Murugeswari, Ponnalagu; Chakrabarty, Koushik; Jayadev, Chaitra; Matalia, Himanshu; Ghosh, Arkasubhra; Das, Debashish
Title: Stem cell therapy in COVID-19 – current evidence and future potential
  • Cord-id: 2k736hvr
  • Document date: 2020_11_9
  • ID: 2k736hvr
    Snippet: The end of 2019 saw the beginning of the COVID-19 pandemic that soared in 2020, affecting 215 countries worldwide with no signs of abating. In an effort to contain the spread of the disease and treat the infected, researchers are racing against several odds to find an effective solution. The unavailability of timely and affordable or definitive treatment has caused significant morbidity and mortality. Acute respiratory distress syndrome (ARDS) caused by an unregulated host inflammatory response
    Document: The end of 2019 saw the beginning of the COVID-19 pandemic that soared in 2020, affecting 215 countries worldwide with no signs of abating. In an effort to contain the spread of the disease and treat the infected, researchers are racing against several odds to find an effective solution. The unavailability of timely and affordable or definitive treatment has caused significant morbidity and mortality. Acute respiratory distress syndrome (ARDS) caused by an unregulated host inflammatory response towards the viral infection, followed by multi-organ dysfunction or failure, is one of the primary causes of deaths in severe cases of COVID-19 infection. Currently, empirical management of respiratory and hematological manifestations along with anti-viral agents are being used to treat the infection. The quest is on for both a vaccine and more a definitive management protocol to curtail the spread. Researchers and clinicians are also exploring the possibility of using cell therapy for severe cases of COVID-19 with ARDS. Mesenchymal stem cells are known to have immunomodulatory properties and have previously been used to treat viral infections. This review explores the potential of mesenchymal stem cells as cell therapy for ARDS.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute ards respiratory distress syndrome and liver transplantation: 1, 2, 3
    • acute ards respiratory distress syndrome and lung infection vulnerable: 1
    • acute ards respiratory distress syndrome and lymph node: 1, 2
    • acute ards respiratory distress syndrome and macrophage lymphocyte: 1, 2
    • acute respiratory and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and liver transplantation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and lung infection vulnerable: 1, 2
    • acute respiratory and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and macrophage lymphocyte: 1, 2, 3, 4
    • acute respiratory sars syndrome corona and liver disease: 1, 2, 3, 4, 5
    • acute respiratory sars syndrome corona and liver transplantation: 1
    • adipose tissue and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • adipose tissue and liver transplantation: 1
    • adipose tissue and lymph node: 1, 2, 3, 4
    • liver disease and lymph node: 1, 2, 3
    • liver transplantation and lymph node: 1